openPR Logo
Press release

Lung Cancer Market Research and Clinical Briefing on Key Developments Trends, Analysis and Forecasts Till 2023

10-16-2018 05:30 PM CET | Health & Medicine

Press release from: MarketResearchFuture

Lung Cancer Market Research and Clinical Briefing on Key

Lung Cancer Market - Business Overview:

The Global Lung Cancer Market is growing mainly due to the changing lifestyle, and environmental pollution. According to a recent study report published by the Market Research Future, The lung cancer market is booming and expected to gain prominence over the forecast period. The market is forecasted to demonstrate a spectacular growth by 2023, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2023).

Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in lung tissue with symptoms such as coughing, weight loss, and fatigue and chest pain. The two types of lung cancers are small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC). The NSCLC type accounts for almost 80% of the total lung cancers. The cure rates for the two types of lung cancers exchange their positions with the SCLC being the most malignant. The cure rates also depend on the stage of cancer detection with rates varying by 55% for first stage to just 1% for stage four.

Get Exclusive Sample Report @ https://www.marketresearchfuture.com/sample_request/1185 .
Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in lung tissue with symptoms such as coughing, weight loss, and fatigue and chest pain. The two types of lung cancers are small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC). The NSCLC type accounts for almost 80% of the total lung cancers. The cure rates for the two types of lung cancers exchange their positions with the SCLC being the most malignant. The cure rates also depend on the stage of cancer detection with rates varying by 55% for first stage to just 1% for stage four.

Almost 85% of cases of lung cancer are due to long-term tobacco smoking. Cigarette smoke contains at least 73 known carcinogens. Other factors causing lung cancer are genetic factors and exposure to triggers and carcinogens such as radon gas, asbestos, radioactive materials, second-hand smoke, or air pollution. It has also been demonstrated that passive smokers have a 20–30% increase in risk.

Lung Cancer Market - Competitive Analysis:

The lung cancer market is currently dominated by various players. Lung cancer has become one of the nost common causes of cancer death worldwide. So, in recent years various existing and new marketers are continuously coming up with innovative products to control this condition.

For instance, F. Hoffmann-La Roche Ltd, a Switzerland based company, manufactures various cancer treatment products such as anti-bcl-2 (SP66) Rabbit Monoclonal Primary Antibody, anti-c-MYC (Y69) Rabbit Monoclonal Primary Antibody, anti-CD7 (SP94) Rabbit Monoclonal Primary Antibody, anti-CEA (TF 3H8-1) Primary Antibody, anti-Cytokeratin 5/6 (D5/16B4) Mouse Monoclonal Primary Antibody, anti-E-cadherin (EP700Y) Rabbit Monoclonal Primary Antibody, and others. In the year 2013, Roche received FDA approval for Tarceva (erlotinib) tablets and cobas EGFR Mutation Test for specific type of lung cancer.

Lung Cancer Market Segments:

Global Lung Cancer Market has been segmented on the basis of types which comprises of SCLC and NSCLC. On the basis of treatments it is segmented into Surgery, Chemotherapy, Radiotherapy, Photodynamic therapy (PDT) and Laser therapy. On the basis of end users, it includes Hospitals & Clinics, Cancer Research Centers and Laboratories.

Regional Analysis of Global Lung Cancer Market:

The global market for Lung Cancer is growing steadily. The global lung cancer market on the basis of region comprises of North America, Europe, Asia Pacific and Middle East & Africa. The global market for Lung Cancer is growing with the CAGR of 13.5% during the forecast period from 2017-2023. NSCLC is the most common type of lung cancer globally. The global Lung Cancer market reached USD 36929.8 million in 2023 from 15219.7 million in 2016. Europe region captured the second largest market globally and is expected to reach USD 8,536.3 million by 2023 due to the growing demand and need for lung cancer drugs, and the growing prevalence of lung cancer.

Get Discount @ https://www.marketresearchfuture.com/check-discount/1185 .

Major TOC for Lung Cancer Market Research Report - Global Forecast to 2023:

1 REPORT PROLOGUE

2 INTRODUCTION

2.1 Research Objective

2.2 Assumptions & Limitations

2.2.1 Assumptions

2.2.2 Limitations

2.3 Market Structure

3 RESEARCH METHODOLOGY

3.1 Primary Research

3.2 Secondary Research

4 PORTERS FIVE FORCES

4.1 Introduction

4.2 Bargaining Power Of Buyer

4.3 Bargaining Power Of Suppliers

4.3.1 Threat From Substitute

4.3.2 Threat From A New Entrant

4.3.3 Intensity Of Competitive Rivalry

….T.O.C continued

Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/1185 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lung Cancer Market Research and Clinical Briefing on Key Developments Trends, Analysis and Forecasts Till 2023 here

News-ID: 1307777 • Views:

More Releases from MarketResearchFuture

Miglitol Market Report Size, Share, and Forecast 2032 | Novartis ,Daiichi Sankyo ,Teva Pharmaceutical Industries
Miglitol Market Report Size, Share, and Forecast 2032 | Novartis ,Daiichi Sankyo …
According to WGR's most recent report, the Miglitol Market 2024-2032 is anticipated to grow rapidly over the coming years. Through the process of research, consolidation, market size, overview, and review of data obtained from multiple sources, the Miglitol Market report provides a meaningful representation of the region. In the Miglitol Market Study, you will find details about market dynamics, drivers, restraints, challenges, threats, potential growth opportunities, market trends, development patterns, financial
Smart Fleet Management Market Size, Share Demand Rising Worldwide 2030
Smart Fleet Management Market Size, Share Demand Rising Worldwide 2030
Market Outlook: The Smart Fleet Management market is estimated to attain a valuation of USD 605.7 billion by the end of 2030, states a study by Market research Future (MRFR). Besides, the report notes that the Smart Fleet Management market is prognosticated to expand at a CAGR of 10.1% during the forecast period, 2023-2030. Smart fleet management is experiencing significant market trends driven by advancements in technology and evolving industry needs. One
Automotive Heat Shield Market Size, Share, Demand Trends and Forecasts to 2032
Automotive Heat Shield Market Size, Share, Demand Trends and Forecasts to 2032
According to projections, the Automotive Heat Shield market will expand at a compound annual growth rate (CAGR) of 3.8% from USD 15825.1 million in 2021 to USD 18759.1 million in 2032. Heat shields are used to shield a device's internal components from heat produced by the core. In the automotive industry, the heat shield is utilized to reduce the excessive heat generated by internal combustion engines. Heat shields are most frequently
Automotive Filters Market Size, Share, Business Key Players, Forecast By 2032
Automotive Filters Market Size, Share, Business Key Players, Forecast By 2032
The size of the automotive Automotive Filters market was estimated at USD 25.1 billion in 2022. With a compound annual growth rate (CAGR) of 3.00% over the forecast period (2023-2032), the automotive Automotive Filters market industry is expected to expand from USD 25.8 billion in 2023 to USD 32.7 billion by 2032. The main factors propelling the market's expansion are rising sales, the need for automobile Automotive Filters, and the

All 5 Releases


More Releases for Lung

Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: Core Growth Enabler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Lung Cancer Drugs Industry Market Size Be by 2025? The market for lung cancer medications has seen a swift expansion in previous years. The market size is projected to escalate from $47.94 billion in 2024 to $54.13 billion in 2025, with a compound annual growth rate
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: An Emerging Driver …
The Lending And Payments Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Lending And Payments Market? The lending and payments market has experienced strong growth in recent years. It is set to rise from $12,326.44 billion in 2024 to
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market? The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market? The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and
Lung Cancer Screening Market - Empowering Proactive Lung Health: The Future of C …
Newark, New Castle, USA: The "Lung Cancer Screening Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Lung Cancer Screening Market: https://www.growthplusreports.com/report/lung-cancer-screening-market/7787 This latest report researches the industry structure,
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor